Immediate Impact
31 standout
Citing Papers
Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Works of Megha Poddar being referenced
Practical Considerations and Rationale for Glucagon-Like Peptide-1 Receptor Agonist Plus Sodium-Dependent Glucose Cotransporter-2 Inhibitor Combination Therapy in Type 2 Diabetes
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Megha Poddar | 43 | 81 | 15 | 46 | 11 | 169 | |
| Achintya Mitra | 57 | 57 | 15 | 23 | 18 | 172 | |
| Neda Seyedsadjadi | 33 | 31 | 17 | 55 | 17 | 272 | |
| Catherine Zahner | 65 | 52 | 15 | 52 | 13 | 258 | |
| A B Vaidya | 47 | 47 | 40 | 47 | 20 | 258 | |
| Utibe‐Abasi S. Udoh | 31 | 33 | 21 | 85 | 17 | 277 | |
| Sibyl N. Swift | 29 | 37 | 19 | 65 | 12 | 277 | |
| Siriporn Tiamkao | 15 | 82 | 16 | 60 | 26 | 261 | |
| Zhaoxiang Bian | 11 | 61 | 25 | 45 | 12 | 215 | |
| Nadia Ghannam | 61 | 39 | 27 | 49 | 7 | 278 | |
| Fatemeh Amini | 37 | 20 | 24 | 41 | 15 | 252 |
All Works
Loading papers...